Practicing physicians have requested efficacy and safety data for belimumab, when used with specific systemic lupus erythematosus (SLE) medications. This was a post hoc analysis of pooled efficacy and safety data from patients who received belimumab 10 mg/kg plus standard of care (SoC) or placebo (SoC) in two Phase III, randomized trials, BLISS-52 and BLISS-76. Patients were categorized into four groups based on baseline concomitant medication usage: steroids only; antimalarials (AM) only; steroids + AM; or steroids + AM + immunosuppressants (IS). The primary endpoint was the SLE Responder Index (SRI) at Week 52. SRI over time and individual SRI components were secondary endpoints. Time to first flare and changes in concomitant medications ...
Objective: To investigate efficacy, safety and survival of belimumab and to identify predictors of d...
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by multisystemic in...
AbstractPurposeBelimumab is an approved therapy for the treatment of systemic lupus erythematosus (S...
Practicing physicians have requested efficacy and safety data for belimumab, when used with specific...
OBJECTIVE: To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with system...
Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combi...
Objective. To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combi...
Background: Belimumab is the unique biologic therapy available for patients with SLE. Objectives: To...
OBJECTIVE: To investigate effectiveness and safety of belimumab in patients with active systemic l...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149757/1/art40861_am.pdfhttps://deepbl...
Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentat...
Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentat...
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness...
BACKGROUND: There is limited evidence that rituximab, a B cell depletion therapy, is an effective tr...
OBJECTIVE: To evaluate the effects of belimumab versus placebo, plus standard systemic lupus erythe...
Objective: To investigate efficacy, safety and survival of belimumab and to identify predictors of d...
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by multisystemic in...
AbstractPurposeBelimumab is an approved therapy for the treatment of systemic lupus erythematosus (S...
Practicing physicians have requested efficacy and safety data for belimumab, when used with specific...
OBJECTIVE: To assess the efficacy and safety of subcutaneous (SC) belimumab in patients with system...
Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combi...
Objective. To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combi...
Background: Belimumab is the unique biologic therapy available for patients with SLE. Objectives: To...
OBJECTIVE: To investigate effectiveness and safety of belimumab in patients with active systemic l...
Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/149757/1/art40861_am.pdfhttps://deepbl...
Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentat...
Systemic lupus erythematosus (SLE) is a complex autoimmune rheumatic disease with multiple presentat...
Objectives: To undertake a systematic review and meta-analysis to investigate clinical effectiveness...
BACKGROUND: There is limited evidence that rituximab, a B cell depletion therapy, is an effective tr...
OBJECTIVE: To evaluate the effects of belimumab versus placebo, plus standard systemic lupus erythe...
Objective: To investigate efficacy, safety and survival of belimumab and to identify predictors of d...
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease characterized by multisystemic in...
AbstractPurposeBelimumab is an approved therapy for the treatment of systemic lupus erythematosus (S...